Literature DB >> 16960899

Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.

Robert F Ritchie1, Glenn E Palomaki, Louis M Neveux, Thomas B Ledue, Santica Marcovina, Olga Navolotskaia.   

Abstract

Limiting the clinical utility of apolipoproteins AI (apo AI) and B (apo B) and the apo B/AI ratios until the last decade has been the lack of satisfactory methods for quantifying serum levels and credible reference materials. Great technological strides have been made in the last few years. The remaining barrier to more relevant and cost-effective use of serum protein data for diagnosis and prognosis has been the availability of widely recognized reliable reference intervals from birth to old age for both males and females. A total of 82 publications reporting reference intervals have been identified that meet most of the same inclusion criteria used in our prior six studies. These have been analyzed statistically and compared to similar studies, i.e., sufficient number, listed subject criteria, method, and reference material, in general terms. Published smaller studies with constrained age ranges, agree on average with our large series of life-long reference intervals that range from less than one year to over 80 years. This study was performed to assess the degree of agreement between smaller reference interval studies to our large population analysis. This meta-analysis provides support and reassurance that many of the smaller reference intervals published previously fall within reasonable limits of out large population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960899      PMCID: PMC6807339          DOI: 10.1002/jcla.20135

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  99 in total

1.  Pre-beta high-density lipoprotein determined by immunoblotting with chemiluminescent detection.

Authors:  M J O'Kane; G B Wisdom; J McEneny; N V McFerran; E R Trimble
Journal:  Clin Chem       Date:  1992-11       Impact factor: 8.327

2.  Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction.

Authors:  G De Backer; F Hulstaert; K De Munck; M Rosseneu; L Van Parijs; M Dramaix
Journal:  Am Heart J       Date:  1986-09       Impact factor: 4.749

3.  Tracking of serum apolipoproteins A-I and B in children and young adults: the Bogalusa Heart Study.

Authors:  W Bao; S R Srinivasan; G S Berenson
Journal:  J Clin Epidemiol       Date:  1993-07       Impact factor: 6.437

4.  The effect of two different 18-week walking programmes on aerobic fitness, selected blood lipids and factor XIIa.

Authors:  K Woolf-May; E M Kearney; D W Jones; R C Davison; D Coleman; S R Bird
Journal:  J Sports Sci       Date:  1998-11       Impact factor: 3.337

5.  Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.

Authors:  J D Bagdade; P V Subbaiah
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

6.  Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; M Poapst; J Davignon; S Lussier-Cacan; B Reeder; R Lessard; R A Hegele; A Csima
Journal:  Can J Cardiol       Date:  1999-04       Impact factor: 5.223

7.  Enzyme-linked immunosorbent assay for human plasma apolipoprotein B.

Authors:  J M Ordovas; J P Peterson; P Santaniello; J S Cohn; P W Wilson; E J Schaefer
Journal:  J Lipid Res       Date:  1987-10       Impact factor: 5.922

8.  Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.

Authors:  C J Chang; J T Kao; T J Wu; F H Lu; T Y Tai
Journal:  Diabetes Care       Date:  1995-08       Impact factor: 19.112

9.  Commutability assessment of potential reference materials using a multicenter split-patient-sample between-field-methods (twin-study) design: study within the framework of the Dutch project "Calibration 2000".

Authors:  Henk Baadenhuijsen; Herman Steigstra; Christa Cobbaert; Aldy Kuypers; Cas Weykamp; Rob Jansen
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

10.  High-density lipoprotein particles in octogenarians.

Authors:  G Luc; J M Bard; S Lussier-Cacan; D Bouthillier; H J Parra; J C Fruchart; J Davignon
Journal:  Metabolism       Date:  1991-12       Impact factor: 8.694

View more
  1 in total

1.  Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Wendy Y Craig; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.